https://www.selleckchem.com/pr....oducts/edralbrutinib
More patients in the matched CH group experienced a repeat hepatectomy for recurrence and no patients in this group underwent a preoperative portal vein embolization. The short- and long-term surgical outcomes of CH and MH for a centrally located HCC are similar under a matched clinicopathological background. CH has the advantage of not requiring a preoperative portal vein embolization and increased chances of conducting a repeat hepatectomy for recurrence. The short- and long-term surgical outcomes of CH and MH for a centrally lo
Mi piace
Commento
Condividi
